AMOMED Pharma GmbH is a privately-owned, international pharmaceutical company based in Vienna, Austria. Since its founding in 2003, AMOMED has established itself as a specialist in pharmaceuticals for intensive care, emergency medicine, anesthesia, and neurology. The company focuses on providing essential medicines and innovative treatments for critical and life-threatening conditions. AMOMED aims to ensure the availability of well-established active ingredients and to introduce novel therapeutic options to improve patient outcomes in acute clinical settings across Europe.
The Vienna headquarters serves as the central hub for AMOMED's global operations, including strategic planning, research and development oversight, commercial strategy, marketing, regulatory affairs, and corporate administration.
Located in the modern ICON TOWER, a landmark office complex near Vienna's main railway station (Wien Hauptbahnhof), offering advanced infrastructure and excellent connectivity.
The work culture at AMOMED Pharma GmbH likely emphasizes innovation, collaboration, and a strong focus on patient well-being, driven by the critical nature of their product portfolio. It encourages expertise in a fast-paced, regulated environment.
Vienna's strategic location in Central Europe, its strong pharmaceutical ecosystem, and excellent infrastructure make it an ideal base for a company with pan-European operations and ambitions.
AMOMED Pharma GmbH has a significant presence across Europe, operating in more than 25 countries through its own subsidiaries and a network of distribution partners. Their global functions primarily support the European market, encompassing product development liaison, manufacturing oversight (often with CMOs), comprehensive regulatory affairs for EU countries, pharmacovigilance, pan-European marketing and sales strategies, and medical support for their specialized product portfolio in critical care and related therapeutic areas.
ICON TOWER, Wiedner Gürtel 13, Turm 24, 16. OG
Vienna
Vienna
Austria
Address: AMOMED Pharma operates through a network of local branches, subsidiaries, and distribution partners. Specific office addresses vary by country.
To ensure local market access, tailor commercial strategies to national requirements, engage with local healthcare professionals, manage local regulatory compliance, and provide on-the-ground support in key European markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AOP Orphan Pharmaceuticals AG' leadership includes:
AOP Orphan Pharmaceuticals AG has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major announced executive hires or exits at AMOMED Pharma GmbH in the last 12 months, suggesting stability in the core leadership team.
Discover the tools AOP Orphan Pharmaceuticals AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AMOMED Pharma GmbH likely follows common corporate email formatting conventions. The most probable formats are [first_initial].[last]@[domain] or [first].[last]@[domain].
f.last@amomed.com or first.last@amomed.com (e.g., g.nebel@amomed.com)
Format
g.nebel@amomed.com
Example
80%
Success rate
amomed.com • 2024-06-10
AMOMED Pharma announced its participation in the DGIIN (German Interdisciplinary Association for Intensive Care and Emergency Medicine) Congress 2024 in Hamburg. This highlights their ongoing commitment to the fields of intensive care and emergency medicine through engagement with key medical professionals and societies....more
amomed.com • 2023-11-20
AMOMED Pharma participated in the DIVI (German Interdisciplinary Association for Intensive and Emergency Medicine) Congress 2023 in Hamburg, showcasing their products and engaging with experts in critical care. This participation underscores their focus on innovation and collaboration within the medical community....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AOP Orphan Pharmaceuticals AG, are just a search away.